Leef Brands (LEEEF) Debt Ratio (2024 - 2026)
Leef Brands (LEEEF) reported Debt Ratio of 0.25 for Q1 2026, down 16.85% sequentially from 0.31 in Q4 2025.
Leef Brands (LEEEF) Debt Ratio (2024 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 3 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.25; the trailing twelve-month figure through Mar 2026 stood at 0.25 (changed N/A YoY), and the FY2025 full-year result was 0.31, up 18.49% from the prior year.
- Debt Ratio declined to 0.25 in Q1 2026, from 0.31 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.31 in Q4 2025 to a low of 0.25 in Q1 2026.
- A 3-year average of 0.27 and a median of 0.26 in 2024 frame the typical range for Debt Ratio.
- Peak annual rise in Debt Ratio reached 18.49% in 2025, while the deepest fall reached 18.49% in 2025.
- Tracing LEEEF's Debt Ratio over 3 years: stood at 0.26 in 2024, then climbed by 18.49% to 0.31 in 2025, then slipped by 16.85% to 0.25 in 2026.
- Business Quant data shows LEEEF's Debt Ratio at 0.25 in Q1 2026, 0.31 in Q4 2025, and 0.26 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.26 |